Global Nuclear Medicine Market Outlook to 2028: The Use of Radiopharmaceuticals in Neurological Applications Presents Opportunities

Global Nuclear Medicine Market Outlook to 2028: The Use of Radiopharmaceuticals in Neurological Applications Presents Opportunities

company logo

Dublin, Nov. 16, 2022 (GLOBE NEWSWIRE) — The report “Nuclear Medicine Market: Global Industry Analysis, Trends, Market Size and Forecast to 2028” has been added to from ResearchAndMarkets.com offer.

The global nuclear medicine market report provides qualitative and quantitative analysis for the period 2020 to 2028.

The report forecasts that the global nuclear medicine market is expected to grow with a CAGR of almost 10% over the forecast period from 2022 to 2028.

The study on the Nuclear Medicine market covers the analysis of major geographies such as North America, Europe, Asia-Pacific, and ROW for the period 2020 to 2028.

The Nuclear Medicine Market report is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts and trends of the global Nuclear Medicine market in the period from 2020 to 2028. Additionally, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insight into the competitive rivalry, market vendor and buyer positions, and opportunities for new entrants in the global Nuclear Medicine market over the period 2020 to 2028 Additionally, IGR-Growth Matrix has given in the report provides an overview of investment areas that existing or new market players can consider.

Report results

1) Drivers

2) Constraints

3) Opportunities

What does this report bring?
1. Comprehensive analysis of global and regional markets of Nuclear Medicine market.
2. Comprehensive coverage of all segments of the Nuclear Medicine market to analyze trends, global market developments and market size forecast till 2028.
3. Comprehensive analysis of the companies operating in the global nuclear medicine market. The company profile includes product portfolio analysis, revenue, SWOT analysis and latest company developments.
4. IGR- Growth Matrix presents an analysis of product segments and geographies that market players should focus on to invest, consolidate, grow and/or diversify.

Main topics covered:

1. Preface

2. Executive Summary

3. Global Nuclear Medicine Market Overview
3.1. Introduction
3.2. Market dynamics
3.2.1. Drivers
3.2.2. Constraints
3.2.3. Opportunities
3.3. Analysis of the impact of COVID-19 on the Nuclear Medicine Market
3.4. Porter’s Five Forces Analysis
3.5. IGR Growth Matrix Analysis
3.5.1. IGR Growth Matrix Analysis by Product
3.5.2. IGR Growth Matrix Analysis by Application
3.5.3. IGR Growth Matrix Analysis by Region
3.6. Nuclear Medicine Market Value Chain Analysis

4. Nuclear Medicine Market Macro Indicators Analysis

5. Global Nuclear Medicine Market by Product
5.1. Diagnostic products
5.1.1. SPECT
5.1.2. ANIMALS
5.2. Therapeutic products
5.2.1. Alpha Emitters
5.2.2. Beta emitters
5.2.3. Brachytherapy

6. Global Nuclear Medicine Market by Application
6.1. Cardiology
6.2. Neurology
6.3. Oncology
6.4. Thyroid
6.5. Lymphoma
6.6. Others

7. Global Nuclear Medicine Market by Region 2022-2028
7.1. North America
7.1.1. North America Nuclear Medicine Market by Product
7.1.2. North America Nuclear Medicine Market by Application
7.1.3. North America Nuclear Medicine Market by Country
7.2. Europe
7.2.1. Europe Nuclear Medicine Market by Product
7.2.2. European Nuclear Medicine Market by Application
7.2.3. Europe Nuclear Medicine Market by Country
7.3. Asia Pacific
7.3.1. Asia-Pacific Nuclear Medicine Market by Product
7.3.2. Asia-Pacific Nuclear Medicine Market by Application
7.3.3. Asia-Pacific Nuclear Medicine Market by Country
7.4. Line
7.4.1. RoW Nuclear Medicine Market by Product
7.4.2. RoW Nuclear Medicine Market by Application
7.4.3. RoW Nuclear Medicine Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive landscape in the global nuclear medicine market
8.2. Profiled companies
8.2.1. GE Healthcare
8.2.2. Mallinckrodt plc.
8.2.3. Norgine B.V.
8.2.4. Medtronic, Inc.
8.2.5. Bayer AG
8.2.6. Cardinal Health, Inc.
8.2.7. Lantheus Medical Imaging, Inc.
8.2.8. IBA Group
8.2.9. Nordion, Inc.
8.2.10. Advanced Accelerator Applications SA

For more information about this report visit https://www.researchandmarkets.com/r/gchq6q

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

#Global #Nuclear #Medicine #Market #Outlook #Radiopharmaceuticals #Neurological #Applications #Presents #Opportunities

Leave a Comment

Your email address will not be published. Required fields are marked *